1. Home
  2. Companies
  3. Alnylam Pharmaceuticals
  4. Financial Ratios
  5. DSO Ratio
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals ALNY
$ 322.11 0.26%

Annual report 2025
added 02-12-2026

report update icon

Alnylam Pharmaceuticals DSO Ratio 2011-2026 | ALNY

Annual DSO Ratio Alnylam Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
58.1 41 13.2 18.6 23.1 17.9 71.4 91.4 138 181 73.7 288 32.9 0.569 6.47

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
288 0.569 70.4

Quarterly DSO Ratio Alnylam Pharmaceuticals

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
58.1 63.2 - 60.4 43.6 59.9 - 33.2 63 65.4 - 3.79 4.75 20.7 - 14 11 13.5 18.7 24.3 29.4 22.2 19 19.4 30.5 28.2 24.4 248 17.2 82.6 58.5 80.2 141 138 - - - - - - - - - - - - - - - - - -5.88 -8.33 -80.7 - -287 -132 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
248 -287 28.1

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		222 - - $ 86.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		48.3 - -24.86 % $ 820 K usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Akebia Therapeutics Akebia Therapeutics
AKBA
 		62.9 $ 1.4 -0.71 % $ 360 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
Aravive Aravive
ARAV
 		16.8 - -13.39 % $ 1.45 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 2.92 -0.34 % $ 6.35 B israelIsrael
Aytu BioScience Aytu BioScience
AYTU
 		150 $ 2.55 -0.78 % $ 16 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
Advaxis Advaxis
ADXS
 		88.1 - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		70.9 $ 20.37 -2.4 % $ 952 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		103 $ 4.08 -2.16 % $ 436 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 24.21 -1.47 % $ 3.08 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		321 $ 32.24 -4.1 % $ 2.14 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		0.114 - - $ 26.5 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		182 - - $ 3.45 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		45.6 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
 		2.26 K - - $ 1.41 B usaUSA
Immutep Limited Immutep Limited
IMMP
 		351 $ 0.31 -2.52 % $ 1.08 B australiaAustralia
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		6.83 - - $ 169 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		13.6 - - $ 867 M germanyGermany
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		147 - - $ 401 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
 		15.6 - -6.63 % $ 13.9 M usaUSA